Thermo Fisher Scientific Inc. (ETR: TN8)

Market Cap	208.01B
Revenue (ttm)	37.95B
Net Income (ttm)	5.50B
Shares Out	n/a
EPS (ttm)	14.29
PE Ratio	37.85
Forward PE	n/a
Dividend	1.44 (0.26%)
Ex-Dividend Date	Dec 13, 2024

Volume	435
Average Volume	243
Open	547.50
Previous Close	538.60
Day's Range	541.20 - 547.70
52-Week Range	469.65 - 575.60
Beta	n/a
RSI	58.52
Earnings Date	Jan 29, 2025

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechno...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 1956
• Employees: 122,000
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: TN8

Financial Performance

In 2023, Thermo Fisher Scientific's revenue was $42.86 billion, a decrease of -4.58% compared to the previous year's $44.92 billion. Earnings were $6.00 billion, a decrease of -13.74%.

Financial numbers in USD